DiObex's Series B Round

DiObex raised a round of funding on April 05, 2007.

DiObex is a biopharmaceutical company that has one of the lead compounds for the treatment of type 2 diabetes via the innovative cortisol pathway in clinical testing. This new mechanism of action migh…

Articles about DiObex's Series B Round: